700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Research Paper Open Access
Livomyn, an indigenous drug, was studied against hepatic damage induced by the antimycotic drug, ketoconazole, Serum levels of transaminases-alanine aminotransferase (ALT) and aspartate amino-transferase (AST), alkaline phosphates and lipids (cholesterol and triglycerides) were used as the biochemical markers of hepatotoxicity. The results indicate that, in albino rats, Livomyn showed protective effect against ketocanazole-induced hepatotoxicity and consequent liver damage.
To read the full article Peer-reviewed Article PDF
Author(s): R J Kothavade S N Joglekar S A Barodavalla